Mosby's 2014 Nursing Drug Reference (347 page)

BOOK: Mosby's 2014 Nursing Drug Reference
6.12Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

rasburicase (Rx)

(rass-burr′i-case)

Elitek, Fasturtec

Func. class.:
Enzyme

Chem. class.:
Recombinant urate-oxidase enzyme

ACTION:

Catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin)

USES:

To reduce uric acid levels in children with leukemia, lymphoma, solid tumor malignancies who are receiving chemotherapy

CONTRAINDICATIONS:

Hypersensitivity

 

Black Box Warning:

G6PD deficiency (Mediterranean, African descendants), hemolytic reactions, methemoglobinemia reactions to product

Precautions:
Pregnancy (C), breastfeeding, children <2 yr, anemia

 

Black Box Warning:

Acute bronchospasm, angina, angioedema, atony, African-American and Mediterranean patients, hypotension, urticaria

DOSAGE AND ROUTES
Calculator

• Adult/adolescent/infant:
IV INF
0.2 mg/kg as single daily dose given as
IV INF
over 1/2 hr × 5 days

Available forms:
Powder for inj 1.5, 7.5 mg/vial

Administer:
Intermittent IV INF route

• 
Reconstitute with diluent provided, add 1 ml of diluent/each vial, swirl, withdraw amount needed, mix with NS to final volume of 50 ml, use within 24 hr, give over 30 min, do not use filter, use different line; if not possible, flush with ≥15 ml of saline before, after use

• 
Chemotherapy started 4-24 hr after 1st dose

SIDE EFFECTS

CNS:
Headache
, fever

CV:
Chest pain, hypotension

GI:
Nausea, vomiting, anorexia, diarrhea, abdominal pain, constipation, dyspepsia, mucositis

HEMA:
Neutropenia with fever, hemolysis, methemoglobinemia

INTEG:
Rash

MISC:
Edema

RESP:
Bronchospasm,
wheezing, dyspnea

SYST:
Anaphylaxis, hemolysis, methemoglobinemia, sepsis

PHARMACOKINETICS

Elimination half-life 16-21 hr

INTERACTIONS

 
Increase:
toxicity—allopurinol

NURSING CONSIDERATIONS
Assess:

• 
Blood studies: BUN, serum uric acid, urine creatinine clearance, electrolytes, CBC with differential before, during therapy

• 
Monitor temp; fever may indicate beginning infection; no rectal temps

 
Anaphylaxis:
dyspnea, urticaria, flushing, wheezing, swelling of lips, tongue, throat; have emergency equipment nearby

 
G6PD deficiency, hemolytic reactions, methemoglobinemia;
these patients should not be given this product; screen patients who are at higher risk for these disorders

• 
GI symptoms: frequency of stools, cramping; if severe diarrhea occurs, fluid, electrolytes may need to be given

Evaluate:

• 
Therapeutic response: decreased uric acid levels in children when antineoplastics causing high uric acid levels used

Teach patient/family:

• 
About the reason for therapy, expected results

 
To report trouble breathing, jaundice, chest pain

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

HIGH ALERT
remifentanil (Rx)

(rem-ih-fin′ta-nill)

Ultiva

Func. class.:
Opiate agonist analgesic

Chem. class.:
μ-Opioid agonist

Other books

Home Is Where the Bark Is by Kandy Shepherd
Dealing With Discipline by Golden Angel
The Last Speakers by K. David Harrison
Jill Elizabeth Nelson by Legacy of Lies
Incognito by Eagleman, David
Old Sinners Never Die by Dorothy Salisbury Davis
Heroes for My Son by Brad Meltzer